Beta-casomorphin-7: A narrative review of its physiological and pathophysiological effects
2nd International Congress on Solutions in Science (INSCORE), İzmir, Türkiye, 14 - 17 Kasım 2026, ss.1, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Basıldığı Şehir: İzmir
- Basıldığı Ülke: Türkiye
- Sayfa Sayıları: ss.1
- Manisa Celal Bayar Üniversitesi Adresli: Evet
Özet
Beta-casomorphin-7 (BCM-7) is a food-derived opioid heptapeptide released during the proteolytic digestion of bovine β-casein, with greater liberation reported from A1 β-casein than from A2 β-casein. Interest in BCM-7 arises from its capacity to interact with opioid receptors and from reported effects extending beyond the gastrointestinal tract to the nervous, immune, metabolic and respiratory systems. This narrative review aimed to synthesize the physiological and pathophysiological effects of BCM-7 and to critically assess the mechanisms proposed to underlie these actions. Publications addressing BCM-7 that were already included in the underlying thesis literature review were synthesized narratively; no original experimental data from the thesis were included. Evidence was organized around BCM-7 formation and bioavailability, receptor-mediated mechanisms, gastrointestinal and mucosal actions, immune and metabolic effects, neurobehavioral and neurophysiological outcomes, respiratory effects, and disease-related associations. The reviewed literature identifies μ-opioid receptor signaling as a major pathway for several BCM-7 actions, particularly in gastrointestinal and mucosal physiology, whereas findings involving δ-opioid receptors and 5-HT2A receptors indicate that its biological activity may not be exclusively μ-opioid mediated. Experimental and human studies also describe associations with mucus secretion, cellular proliferation and redox/epigenetic regulation, neurodevelopmental and behavioral processes, altered respiratory control, and inflammatory or neurological conditions. However, the strength of evidence varies substantially across experimental models, BCM analogues, routes of administration, and human observational studies, limiting causal interpretation. Overall, BCM-7 appears to be a biologically active milk-derived peptide with multisystem effects, but its physiological relevance and contribution to disease remain incompletely resolved. Mechanistically targeted studies distinguishing receptor-specific actions, bioavailability, tissue exposure, and the effects of native BCM-7 from related casomorphins are required.